Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Glaucoma
What are some methods to deal with IOP elevations with intravitreal injections in a patient without glaucomatous damage that does not want to have AC taps with each injection?
Related Questions
What is your approach to using multifocal or extended depth of focus IOLs in patients with preperimetric glaucoma?
How does a history of malignant glaucoma in one eye influence your surgical approach to the fellow eye, particularly regarding prophylactic/intra-operative measures (i.e., iridotomy, IZH)?
In patients with glaucoma who are not ideal candidates for goniotomy, angle stenting, tubes, or trabeculectomy, does the use of AlloFlo provide safe and predictable IOP control compared to other surgical options?
Who is your ideal candidate for a XEN over other filtering procedures such as trabs or tubes?
How do you monitor glaucoma progression in highly myopic patients with unreliable visual fields and atypical RNFL scans?
Which patients are good candidates for micropulse CPC?
What are the clinical indications for performing a second laser peripheral iridotomy (LPI) instead of proceeding directly with cataract surgery?
What has been your experience with Durysta (bimatoprost implant) for glaucoma management?
What is your perspective on using AI with OCTA to assess optic nerve blood flow in glaucoma management?
How has your use of SLT changed given the 6-year results of the LiGHT trial?
